Organisms | Evidence |
---|---|
Streptomyces kanamyceticus | |
Shigella | |
Serratia rubidaea | |
Cyanospira rippkae (nom. illeg.) |
Pathway Name | Organism |
---|---|
Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | Bos taurus |
Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | Rattus norvegicus |
Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | Homo sapiens |
Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | Gallus gallus |
Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | Xenopus tropicalis |
Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | Sus scrofa |
Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | Canis familiaris |
Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | Mus musculus |
RES 1b:a-dglc-HEX-1:5
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024